Pfizer Overview
Pfizer Target Price
Where could PFE trade next? Consensus target price: $30.
Get informed when a big investor buys or sells
+ FollowShare Price
$30.79
Average Target Price
$30.00
2.6% downside
2.6% downside5 analysts in the last 4 months
High: $33 | Low: $28
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-08 | Cantor FitzgeraldCarter Gould | $28 | 9.1% downside |  |
| 2026-10-06 | Scotiabank | $33 |  7.2% upside | |
| 2026-09-10 | HSBC | $30 | 2.6% downside | |
| 2026-08-07 | Guggenheim | $31 | 0.7% upside | |
| 2026-07-06 | HSBC | $28 | 9.1% downside | |
| 2026-05-27 | UBSMichael Yee | $27 | 12.3% downside | |
| 2026-05-14 | Wolfe ResearchAlexandria Hammond | $26 | 15.6% downside | |
| 2026-03-17 | Morgan StanleyTerence Flynn | $27 | 12.3% downside | |
| 2026-03-09 | BMO CapitalEvan David Seigerman | $30 | 2.6% downside | |
| 2026-02-24 | RBC CapitalTrung Huynh | $25 | 18.8% downside | |
| 2026-02-19 | BarclaysEmily Field | $25 | 18.8% downside | |
| 2026-02-12 | DaiwaNarumi Nakagiri | $27 | 12.3% downside | |
| 2026-01-27 | Cantor Fitzgerald | $27 | 12.3% downside | |
| 2026-01-06 | UBS | $25 | 18.8% downside | |
| 2025-12-17 | Wolfe ResearchAlexandria Hammond | $24 | 22.1% downside | |
| 2025-12-12 | Morgan Stanley | $28 | 9.1% downside | |
| 2025-12-10 | HSBCRajesh Kumar | $29 | 5.8% downside | |
| 2025-11-24 | Guggenheim | $35 | 13.7% upside | |
| 2025-11-05 | Goldman SachsAsad Haider | $26 | 15.6% downside | |
| 2025-10-31 | BernsteinCourtney Breen | $30 | 2.6% downside | |
| 2025-10-10 | Morgan Stanley | $32 | 3.9% upside | |
| 2025-10-01 | UBSTim Anderson | $28 | 9.1% downside | |
| 2025-04-22 | Cantor FitzgeraldCarter Gould | $24 | 22.1% downside | |
| 2024-12-18 | Truist FinancialRobyn Karnauskas | $32 | 3.9% upside | |
| 2024-10-30 | Goldman SachsChris Shibutani | $33 | 7.2% upside | |
| 2024-10-17 | BernsteinCourtney Breen | $32 | 3.9% upside | |
| 2024-09-25 | BarclaysCarter Gould | $32 | 3.9% upside | |
| 2024-08-07 | DaiwaNarumi Nakagiri | $34 | 10.4% upside | |
| 2024-07-31 | Wells FargoMohit Bansal | $30 | 2.6% downside | |
| 2024-07-31 | Goldman SachsChris Shibutani | $34 | 10.4% upside | |
| 2024-07-30 | GuggenheimVamil Divan | $36 | 16.9% upside | |
| 2024-07-10 | BarclaysCarter Gould | $30 | 2.6% downside | |
| 2024-05-22 | BMO CapitalEvan Seigerman | $36 | 16.9% upside | |
| 2024-02-14 | Cantor FitzgeraldLouise Chen | $45 | 46.2% upside | |
| 2023-12-14 | Morgan StanleyThomas Yeh | $20 | 35% downside | |
| 2023-11-27 | Morgan StanleyTerence Flynn | $37 | 20.2% upside | |
| 2023-02-01 | Morgan Stanley | $45 | 46.2% upside | |
| 2023-02-01 | Credit Suisse | $50 | 62.4% upside | |
| 2023-02-01 | Barclays | $44 | 42.9% upside | |
| 2023-02-01 | Atlantic Equities | $46 | 49.4% upside | |
| 2023-02-01 | Leerink Partners | $48 | 55.9% upside | |
| 2022-12-14 | Morgan Stanley | $53 | 72.1% upside | |
| 2022-12-13 | Goldman SachsChris Shibutani | $60 | 94.9% upside | |
| 2022-11-18 | Credit Suisse | $55 | 78.6% upside | |
| 2022-05-23 | Leerink PartnersDavid Risinger | $55 | 78.6% upside | |
| 2022-05-10 | Wells FargoMohit Bansal | $54.42 | 76.7% upside | |
| 2022-05-09 | Wells FargoMohit Bansal | $55 | 78.6% upside | |
| 2022-05-04 | Morgan Stanley | $52 | 68.9% upside | |
| 2022-05-02 | Mizuho SecuritiesVamil Divan | $55 | 78.6% upside | |
| 2022-04-15 | Cantor FitzgeraldLouise Chen | $75 | 143.6% upside | |